RSS-Feed abonnieren
DOI: 10.1055/s-0028-1085094
Budd-Chiari Syndrome
Publikationsverlauf
Publikationsdatum:
23. September 2008 (online)
ABSTRACT
Primary Budd–Chiari syndrome is related to thrombosis of hepatic veins or the terminal portion of the inferior vena cava. This rare disease is usually caused by multiple concurrent factors, including acquired and inherited thrombophilias. Half of the patients with primary Budd–Chiari syndrome are affected with a myeloproliferative disease, the recognition of which is largely based on the assessment of V617F Janus tyrosine kinase 2 (JAK2) mutation in peripheral granulocytes. A diagnosis of Budd–Chiari syndrome should be considered in any patient presenting with acute or chronic liver disease, as clinical manifestations are extremely diverse. Spontaneous outcome in symptomatic patients is poor. Diagnosis can be made in most patients noninvasively when imaging shows venous obstruction and/or collaterals. A treatment strategy is recommended where anticoagulation is given first, followed by angioplasty when appropriate, then TIPS in patients not responding to previous measure, and finally liver transplantation. This strategy has achieved 5-year survival rates close to 90%.
KEYWORDS
Myeloproliferative disease - thrombosis - thrombophilia - transjugular intrahepatic portosystemic shunt - anticoagulation - angioplasty - liver transplantation
REFERENCES
- 1 Janssen H L, Garcia-Pagan J C, Elias E, Mentha G, Hadengue A, Valla D C. Budd-Chiari syndrome: a review by an expert panel. J Hepatol. 2003; 38 364-371
- 2 de Franchis R. Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005; 43(1) 167-176
- 3 Ludwig J, Hashimoto E, McGill D, Heerden J V. Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc. 1990; 65 51-55
- 4 Shrestha S M, Okuda K, Uchida T et al.. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol. 1996; 11 170-179
- 5 Valla D. Hepatic venous outflow tract obstruction etipathogenesis: Asia versus the West. J Gastroenterol Hepatol. 2004; 19 S204-S211
- 6 Darwish-Murad S, Plessier A, Hernandez-Guerra M et al.. A prospective study on 163 pattients with Budd-Chiari syndrome: results from the European Network for Vascular Disorders of the Liver (EN-VIE). J Hepatol. 2007; 46 S4
- 7 Valla D C. Hepatic vein thrombosis (Budd-Chiari syndrome). Semin Liver Dis. 2002; 22 5-14
- 8 Okuda K. Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy). Semin Liver Dis. 2002; 22 15-26
- 9 Mehrotra G, Singh R P, Krishna A, Singh B K. Pyogenic liver abscess causing acute Budd-Chiari syndrome. Ann Trop Paediatr. 1992; 12 451-453
- 10 Uddin W, Ramage J K, Portmann B et al.. Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment. Gut. 1995; 36 142-145
- 11 Rangheard A S, Vilgrain V, Audet P et al.. Focal nodular hyperplasia inducing hepatic vein obstruction. AJR Am J Roentgenol. 2002; 179 759-762
- 12 Kubo T, Shibata T, Itoh K et al.. Outcome of percutaneous transhepatic venoplasty for hepatic venous outflow obstruction after living donor liver transplantation. Radiology. 2006; 239 285-290
- 13 Wang S L, Sze D Y, Busque S et al.. Treatment of hepatic venous outflow obstruction after piggyback liver transplantation. Radiology. 2005; 236 352-359
- 14 Balian A, Valla D, Naveau S et al.. Post-traumatic membranous obstruction of the inferior vena cava associated with a hypercoagulable state. J Hepatol. 1998; 28 723-726
- 15 Markert D J, Shanmuganathan K, Mirvis S E, Nakajima Y, Hayakawa M. Budd-Chiari syndrome resulting from intrahepatic IVC compression secondary to blunt hepatic trauma. Clin Radiol. 1997; 52 384-387
- 16 Kim P N, Mitchell D G, Outwater E K. Budd-Chiari syndrome: hepatic venous obstruction by an elevated diaphragm. Abdom Imaging. 1999; 24 267-271
- 17 Hirshberg B, Shouval D, Fibach E, Friedman G, Ben-Yehuda D. Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome. J Hepatol. 2000; 32 574-578
- 18 Janssen H L, Meinardi J R, Vleggaar F P et al.. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood. 2000; 96 2364-2368
- 19 Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India. Hepatology. 2001; 34 666-670
- 20 Deltenre P, Denninger M H, Hillaire S et al.. Factor V Leiden related Budd-Chiari syndrome. Gut. 2001; 48 264-268
- 21 Lin G L, Xu P Q, Qi H, Lian J H, Zheng H, Dang X W. Relations of Budd-Chiari syndrome to prothrombin gene mutation. Hepatobiliary Pancreat Dis Int. 2004; 3 214-218
- 22 Kumar S I, Kumar A, Srivastava S, Saraswat V A, Aggarwal R. Low frequency of factor V Leiden and prothrombin G20210A mutations in patients with hepatic venous outflow tract obstruction in northern India: a case-control study. Indian J Gastroenterol. 2005; 24 211-215
- 23 Colak Y, Karasu Z, Oruc N et al.. Hyperhomocysteinaemia and factor V Leiden mutation are associated with Budd-Chiari syndrome. Eur J Gastroenterol Hepatol. 2006; 18 917-920
- 24 Li X M, Wei Y F, Hao H L et al.. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome. Am J Hematol. 2002; 71 11-14
- 25 Dayal S, Pati H P, Pande G K, Sharma M P, Saraya A K. Multilineage hemopoietic stem cell defects in Budd-Chiari syndrome. J Hepatol. 1997; 26 293-297
- 26 Bayraktar Y, Balkanci F, Kansu E et al.. Cavernous transformation of the portal vein: a common manifestation of Behcet's disease. Am J Gastroenterol. 1995; 90 1476-1479
- 27 Patel R K, Lea N C, Heneghan M A et al.. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology. 2006; 130 2031-2038
- 28 Primignani M, Barosi G, Bergamaschi G et al.. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology. 2006; 44 1528-1534
- 29 Kiladjian J J, Cervantes F, Leebeek F W et al.. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis. A report on 241 cases. Blood. 2008; 111(10) 4835-4836
- 30 Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M. Budd-Chiari syndrome: a common complication of Behcet's disease. Am J Gastroenterol. 1997; 92 858-862
- 31 Zylberberg H, Valla D, Viguie F, Casadevall N. Budd-Chiari syndrome associated with 5q deletion and hypereosinophilia. J Clin Gastroenterol. 1996; 23 66-68
- 32 Young I D, Clark R N, Manley P N, Groll A, Simon J B. Response to steroids in Budd-Chiari syndrome caused by idiopathic granulomatous venulitis. Gastroenterology. 1988; 94 503-507
- 33 Rahhal R M, Pashankar D S, Bishop W P. Ulcerative colitis complicated by ischemic colitis and Budd-Chiari syndrome. J Pediatr Gastroenterol Nutr. 2005; 40 94-97
- 34 Dilawari J B, Bambery P, Chawla Y et al.. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore). 1994; 73 21-36
- 35 Khuroo M S, Datta D V. Budd-Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract. Am J Med. 1980; 68 113-121
- 36 Rautou P E, Angermayr B, Raffa S et al.. Maternal and fetal outcome in 27 women with Budd-Chiari syndrome and 41 pregnancies. Hepatology. 2007; 46 563A
- 37 Valla D, Le M G, Poynard T, Zucman N, Rueff B, Benhamou J P. Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. Gastroenterology. 1986; 90 807-811
- 38 Denninger M H, Chait Y, Casadevall N et al.. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology. 2000; 31 587-591
- 39 Parker R GF. Occlusion of the hepatic veins in man. Medicine (Baltimore). 1959; 38 369-402
- 40 Hadengue A, Poliquin M, Vilgrain V et al.. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology. 1994; 106 1042-1047
- 41 Tanaka M, Wanless I R. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology. 1998; 27 488-496
- 42 Cazals-Hatem D, Vilgrain V, Genin P et al.. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. Hepatology. 2003; 37 510-519
- 43 Mahmoud A EA, Helmy A S, Billingham S, Elias E. Poor prognosis and limited therapeutic options in patients with Budd-Chiari syndrome and portal venous system thrombosis. Eur J Gastroenterol Hepatol. 1997; 9 485-489
- 44 Tavill A S, Wood E J, Kreel L, Jones E A, Gregory M, Sherlock S. The Budd-Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. Gastroenterology. 1975; 68 509-518
- 45 Miller W J, Federle M P, Straub W H, Davis P L. Budd-Chiari syndrome: imaging with pathologic correlation. Abdom Imaging. 1993; 18 329-335
- 46 Millener P, Grant E G, Rose S et al.. Color Doppler imaging findings in patients with Budd-Chiari syndrome: correlation with venographic findings. AJR Am J Roentgenol. 1993; 161 307-312
- 47 Chawla Y, Kumar S, Dhiman R K, Suri S, Dilawari J B. Duplex Doppler sonography in patients with Budd-Chiari syndrome. J Gastroenterol Hepatol. 1999; 14 904-907
- 48 Grant E G, Perrella R, Tessler F N, Lois J, Busuttil R. Budd-Chiari syndrome: the results of duplex and color Doppler imaging. AJR Am J Roentgenol. 1989; 152 377-381
- 49 Kane R, Eustace S. Diagnosis of Budd-Chiari syndrome: comparison between sonography and MR angiography. Radiology. 1995; 195 117-121
- 50 DeLeve L D, Shulman H M, McDonald G B. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis. 2002; 22 27-42
- 51 Rector W G, Xu Y H, Goldstein L, Peters R L, Reynolds T B. Membranous obstruction of the inferior vena cava in the United States. Medicine (Baltimore). 1985; 64 134-143
- 52 Gupta S, Barter S, Phillips G W, Gibson R N, Hodgson H J. Comparison of ultrasonography, computed tomography and 99mTc liver scan in diagnosis of Budd-Chiari syndrome. Gut. 1987; 28 242-247
-
53 Mathieu D, Kracht M, Zafrani E, Dhumeaux D, Vasile N.
Budd-Chiari syndrome . Ferrucci J, Matthieu D Advances in Hepatobiliairy Radiology. St Louis; C.V. Mosby Company 1990: 3-28 - 54 Menu Y, Alison D, Lorphelin J M, Valla D, Belghiti J, Nahum H. Budd-Chiari syndrome: US evaluation. Radiology. 1985; 157 761-764
- 55 Baert A L, Fevery J, Marchal G et al.. Early diagnosis of Budd-Chiari syndrome by computed tomography and ultrasonography: report of five cases. Gastroenterology. 1983; 84 587-595
- 56 Van Beers B, Pringot J, Trigaux J P, Dautrebande J, Mathurin P. Hepatic heterogeneity on CT in Budd-Chiari syndrome: correlation with regional disturbances in portal flow. Gastrointest Radiol. 1988; 13 61-66
- 57 Solano F X, Young E, Talamo T S, Dekker A. Constrictive pericarditis mimicking Budd-Chiari syndrome. Am J Med. 1986; 80 113-115
- 58 Shin S H, Chung Y H, Suh D D et al.. Characteristic clinical features of hepatocellular carcinoma associated with Budd-Chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2004; 16 319-324
- 59 Havlioglu N, Brunt E M, Bacon B R. Budd-Chiari syndrome and hepatocellular carcinoma: a case report and review of the literature. Am J Gastroenterol. 2003; 98 201-204
- 60 Moucari R, Rautou P E, Cazals-Hatem D et al.. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors. Gut. 2008; 57(6) 828-835
- 61 Vons C, Smadja C, Franco D, Valla D, Rueff B, Benhamou J P. Successful pregnancy after Budd-Chiari syndrome. Lancet. 1984; 2 975
- 62 Landolfi R, Marchioli R, Kutti J et al.. Efficacy and safety of low-dose aspirin in polycythemia vera. N Engl J Med. 2004; 350 114-124
- 63 De Ledinghen V, Heresbach D, Fourdan O et al.. Anti-inflammatory drugs and variceal bleeding: a case-control study. Gut. 1999; 44 270-273
- 64 Bates S M, Ginsberg J S. Clinical practice. Treatment of deep-vein thrombosis. N Engl J Med. 2004; 351 268-277
- 65 Zeitoun G, Escolano S, Hadengue A et al.. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology. 1999; 30 84-89
- 66 Murad S D, Valla D C, de Groen P C et al.. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology. 2004; 39 500-508
- 67 Plessier A, Sibert A, Consigny Y et al.. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology. 2006; 44 1308-1316
- 68 Eapen C E, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut. 2006; 55 878-884
- 69 Campbell D A, Rolles K, Jamieson N et al.. Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome. Surg Gynecol Obstet. 1988; 166 511-518
- 70 Halff G, Todo S, Tzakis A G, Gordon R D, Starzl T E. Liver transplantation for the Budd-Chiari syndrome. Ann Surg. 1990; 211 43-49
- 71 Zhang C Q, Fu L N, Xu L et al.. Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome. World J Gastroenterol. 2003; 9 2587-2591
- 72 Plessier A, Sibert A, Consigny Y et al.. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology. 2006; 44(5) 1308-1316
- 73 Barrault C, Plessier A, Valla D, Condat B. Non surgical treatment of Budd-Chiari syndrome: a review. Gastroenterol Clin Biol. 2004; 28 40-49
- 74 Sharma S, Texeira A, Texeira P, Elias E, Wilde J, Olliff S P. Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature. J Hepatol. 2004; 40 172-180
- 75 Hernandez-Guerra M, Lopez E, Bellot P et al.. Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome. Hepatology. 2006; 43 27-33
- 76 Valla D, Hadengue A, el Younsi M et al.. Hepatic venous outflow block caused by short-length hepatic vein stenoses. Hepatology. 1997; 25 814-819
- 77 Griffith J F, Mahmoud A E, Cooper S, Elias E, West R J, Olliff S P. Radiological intervention in Budd-Chiari syndrome: techniques and outcome in 18 patients. Clin Radiol. 1996; 51 775-784
- 78 Martin L G, Henderson J M, Millikan W J, Casarella W J, Kaufman S L. Angioplasty for long-term treatment of patients with Budd-Chiari syndrome. AJR Am J Roentgenol. 1990; 154 1007-1010
- 79 Nunez O, de la Cruz G, Molina J et al.. Interventional radiology, angioplasty and TIPS in Budd-Chiari syndrome. Gastroenterol Hepatol. 2003; 26 461-464
- 80 Pelage J P, Denys A, Valla D et al.. Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stents. Eur Radiol. 2003; 13 286-293
- 81 Witte A M, Kool L J, Veenendaal R, Lamers C B, van Hoek B. Hepatic vein stenting for Budd-Chiari syndrome. Am J Gastroenterol. 1997; 92 498-501
- 82 Qiao T, Liu C J, Liu C, Chen K, Zhang X B, Zu M H. Interventional endovascular treatment for Budd-Chiari syndrome with long-term follow-up. Swiss Med Wkly. 2005; 135 318-326
- 83 Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Kobayashi N. Segmental obstruction of the hepatic inferior vena cava treated by transluminal angioplasty. Radiology. 1983; 149 91-96
- 84 Guan H. [Diagnosis and treatment of membraneous obstruction of the inferior vena cava]. Zhonghua Wai Ke Za Zhi. 1990; 28 760-763 783-764
- 85 Sato M, Yamada R, Tsuji K et al.. Percutaneous transluminal angioplasty in segmental obstruction of the hepatic inferior vena cava: long-term results. Cardiovasc Intervent Radiol. 1990; 13 189-192
- 86 Kohli V, Pande G K, Dev V, Reddy K S, Kaul U, Nundy S. Management of hepatic venous outflow obstruction. Lancet. 1993; 342 718-722
- 87 Yang X L, Cheng T O, Chen C R. Successful treatment by percutaneous balloon angioplasty of Budd-Chiari syndrome caused by membranous obstruction of inferior vena cava: 8-year follow-up study. J Am Coll Cardiol. 1996; 28 1720-1724
- 88 Tyagi S, Jain B L, Kumar N, Lahoti D, Arora R. Balloon dilatation of inferior vena cava stenosis in Budd-Chiari syndrome. J Assoc Physicians India. 1996; 44 378-380
- 89 Bilbao J I, Pueyo J C, Longo J M et al.. Interventional therapeutic techniques in Budd-Chiari syndrome. Cardiovasc Intervent Radiol. 1997; 20 112-119
- 90 De B K, Biswas P K, Sen S et al.. Management of the Budd-Chiari syndrome by balloon cavoplasty. Indian J Gastroenterol. 2001; 20 151-154
- 91 Wu T, Wang L, Xiao Q et al.. Percutaneous balloon angioplasty of inferior vena cava in Budd-Chiari syndrome-R1. Int J Cardiol. 2002; 83 175-178
- 92 Mishra T K, Routray S N, Behera M, Patnaik U K, Satapathy C. Percutaneous balloon angioplasty of membranous obstruction of the inferior vena cava. Indian Heart J. 2003; 55 362-364
- 93 Xu K, Feng B, Zhong H et al.. Clinical application of interventional techniques in the treatment of Budd-Chiari syndrome. Chin Med J (Engl). 2003; 116 609-615
- 94 Xiaoming Z, Zhonggao W. Interventional or semi-interventional treatment for Budd-Chiari syndrome. Chin Med Sci J. 2003; 18 111-115
- 95 Khuroo M S, Al-Suhabani H, Al-Sebayel M et al.. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol. 2005; 20 1494-1502
- 96 Lee B B, Villavicencio L, Kim Y W et al.. Primary Budd-Chiari syndrome: outcome of endovascular management for suprahepatic venous obstruction. J Vasc Surg. 2006; 43 101-108
- 97 Furui S, Sawada S, Irie T et al.. Hepatic inferior vena cava obstruction: treatment of two types with Gianturco expandable metallic stents. Radiology. 1990; 176 665-670
- 98 Langlet P, Valla D. Is surgical portosystemic shunt the treatment of choice in Budd-Chiari syndrome?. Acta Gastroenterol Belg. 2002; 65 155-160
- 99 Panis Y, Belghiti J, Valla D, Benhamou J P, Fekete F. Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries. Surgery. 1994; 115 276-281
- 100 Hemming A W, Langer B, Greig P, Taylor B R, Adams R, Heathcote E J. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am J Surg. 1996; 171 176-180 discussion 180-171
- 101 Tang T J, Batts K P, de Groen P C et al.. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol. 2001; 35 338-343
- 102 Langlet P, Escolano S, Valla D et al.. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol. 2003; 39 496-501
- 103 Bachet J B, Condat B, Hagege H et al.. Long term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome. J Hepatol. 2007; 46(1) 60-68
- 104 Feng L S, Peng Q P, Li K et al.. Management of severe Budd-Chiari syndrome: report of 147 cases. Hepatobiliary Pancreat Dis Int. 2004; 3 522-525
- 105 Savader S J, Venbrux A C, Klein A S, Osterman F A. Percutaneous intervention in portosystemic shunts in Budd-Chiari syndrome. J Vasc Interv Radiol. 1991; 2 489-495
- 106 Orloff M J, Daily P O, Orloff S L, Girard B, Orloff M S. A 27-year experience with surgical treatment of Budd-Chiari syndrome. Ann Surg. 2000; 232 340-352
- 107 Bismuth H, Sherlock D J. Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome. Ann Surg. 1991; 214 581-589
- 108 Orloff L A, Orloff M J. Budd-Chiari syndrome caused by Behcet's disease: treatment by side-to-side portacaval shunt. J Am Coll Surg. 1999; 188 396-407
- 109 Ganger D R, Klapman J B, McDonald V et al.. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. Am J Gastroenterol. 1999; 94 603-608
- 110 Ryu R K, Durham J D, Krysl J et al.. Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome. J Vasc Interv Radiol. 1999; 10 799-805
- 111 Slakey D P, Klein A S, Venbrux A C, Cameron J L. Budd-Chiari syndrome: current management options. Ann Surg. 2001; 233 522-527
- 112 Cejna M, Peck-Radosavljevic M, Schoder M et al.. Repeat interventions for maintenance of transjugular intrahepatic portosystemic shunt function in patients with Budd-Chiari syndrome. J Vasc Interv Radiol. 2002; 13 193-199
- 113 Perello A, Garcia-Pagan J C, Gilabert R et al.. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology. 2002; 35 132-139
- 114 Blokzijl H, de Knegt R J. Long-term effect of treatment of acute Budd-Chiari syndrome with a transjugular intrahepatic portosytemic shunt. Hepatology. 2002; 35 1551-1552
- 115 Mancuso A, Fung K, Mela M et al.. TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience. J Hepatol. 2003; 38 751-754
- 116 Kavanagh P M, Roberts J, Gibney R, Malone D, Hegarty J, McCormick P A. Acute Budd-Chiari syndrome with liver failure: the experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol. 2004; 19 1135-1139
- 117 Attwell A, Ludkowski M, Nash R, Kugelmas M. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation. Aliment Pharmacol Ther. 2004; 20 867-873
- 118 Rossle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery. 2004; 135 394-403
- 119 Safka V, Hulek P, Krajina A et al.. Budd-Chiari syndrome and TIPS–twelve years' experience. Cas Lek Cesk. 2005; 144(Suppl 3) 38-42
- 120 Molmenti E P, Segev D L, Arepally A et al.. The utility of TIPS in the management of Budd-Chiari syndrome. Ann Surg. 2005; 241 978-981 discussion 982-973
- 121 Hernandez-Guerra M, Turnes J, Rubinstein P et al.. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology. 2004; 40 1197-1202
- 122 Mentha G, Giostra E, Majno P E et al.. Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. J Hepatol. 2006; 44 520-528
- 123 Shaked A, Goldstein R M, Klintmalm G B, Drazan K, Husberg B, Busuttil R W. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet. 1992; 174 453-459
- 124 Ringe B, Lang H, Oldhafer K J et al.. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology. 1995; 21 1337-1344
- 125 Henderson J M, Warren W D, Millikan W J et al.. Surgical options, hematologic evaluation, and pathologic changes in Budd-Chiari syndrome. Am J Surg. 1990; 159 41-48 discussion 48-50
- 126 Malkowski P, Michalowicz B, Pawlak J et al.. Surgical and interventional radiological treatment of Budd-Chiari syndrome: report of nine cases. Hepatogastroenterology. 2003; 50 2049-2051
- 127 Jamieson N V, Williams R, Calne R Y. Liver transplantation for Budd-Chiari syndrome, 1976–1990. Ann Chir. 1991; 45 362-365
- 128 Srinivasan P, Rela M, Prachalias A et al.. Liver transplantation for Budd-Chiari syndrome. Transplantation. 2002; 73 973-977
- 129 Segev D L, Nguyen G C, Locke J E et al.. Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis. Liver Transpl. 2007; 13 1285-1294
- 130 Melear J M, Goldstein R M, Levy M F et al.. Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders. Transplantation. 2002; 74 1090-1095
- 131 Valla D C. Prognosis in Budd Chiari syndrome after re-establishing hepatic venous drainage. Gut. 2006; 55 761-763
- 132 Min A D, Atillasoy E O, Schwartz M E, Thiim M, Miller C M, Bodenheimer H C. Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transpl Surg. 1997; 3 423-429
- 133 Murad S D, Valla D C, de Groen P C et al.. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol. 2006; 101 83-90
- 134 Chait Y, Condat B, Cazals-Hatem D et al.. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Br J Haematol. 2005; 129 553-560
- 135 Gentil-Kocher S, Bernard O, Brunelle F et al.. Budd-Chiari syndrome in children: report of 22 cases. J Pediatr. 1988; 113 30-38
- 136 Boudhina T, Ghram N, Ben Becher S et al.. Budd-Chiari syndrome in children. Apropos of 7 cases. Arch Fr Pediatr. 1991; 48 243-248
- 137 Odell J A, Rode H, Millar A J, Hoffman H D. Surgical repair in children with the Budd-Chiari syndrome. J Thorac Cardiovasc Surg. 1995; 110 916-923
- 138 Senzolo M, Tibbals J, Cholongitas E, Triantos C K, Burroughs A K, Patch D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther. 2006; 23 767-775
Dominique-Charles VallaM.D.
Service d'Hépatologie, Hôpital Beaujon
100, Boulevard du Général Leclerc, 92118 Clichy Cedex, France
eMail: dominique.valla@bjn.aphp.fr